Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Repeat-dose Study of the Safety and Efficacy of Acuroc Tablets Following Bunionectomy Surgery in Adult Patients

NCT00654069 is registered in ClinicalTrials.gov with Acura Pharmaceuticals Inc. as lead sponsor.

NCT NCT00654069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00654069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Repeat-dose Study of the Safety and Efficacy of Acuroc Tablets Following Bunionectomy Surgery in Adult Patients
Lead sponsor
Acura Pharmaceuticals Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
March 31, 2008
Enrollment
405 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain